Skip to main content Skip to section navigation Skip to footer
Stock Information
chevron_left Back to CastleBiosciences.com
Castle Biosciences, Inc. IR Home
  • Overview
  • News & Events keyboard_arrow_down
    • Press Releases
    • IR Events
    • Presentations
    • In The Media
    • Annual Meeting
    • Email Alerts
  • Company Info keyboard_arrow_down
    • Company Profile
    • Executive Team
    • Annual Reports & Proxy
    • Contacts
    • FAQ
  • Financial Info keyboard_arrow_down
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data keyboard_arrow_down
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings keyboard_arrow_down
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance keyboard_arrow_down
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Corporate Responsibility
  • Resources keyboard_arrow_down
    • Scientific Evidence
  • Stock Information
  • chevron_leftBack to CastleBiosciences.com

In The Media

News & Events

  • Press Releases
  • IR Events
  • Presentations
  • In The Media
  • Annual Meeting
  • Email Alerts
Jul 21, 2026
Innovations in Pharmaceutical Technology: From Sample to Insight: How Spatial Biology is Transforming Cancer Prognosis and Clinical Research
Jul 20, 2026
The Dermatology Digest: New York State Department of Health Approves Castle’s AdvanceAD-Tx Test
Jul 16, 2026
Clinical Lab Products: New York State Approves Castle Biosciences' Gene Expression Test to Guide Atopic Dermatitis Treatment
Jul 14, 2026
Oncology Central: i31-SLNB Test Outperforms MIA Nomogram in Stratifying Sentinel Lymph Node Positivity Risk
Jul 1, 2026
GastroGirl Podcast: Barrett's Esophagus Treatment Options | How to Reduce Esophageal Cancer Risk with Dr. Caitlin Houghton
Jun 30, 2026
American Medical Journal: Using the DecisionDx-Melanoma Test in Clinical Practice
Jun 30, 2026
Empowered Patient Podcast: Advanced Molecular Diagnostics Transform Skin Cancer Risk Stratification with Dr. Matthew Goldberg Castle Biosciences
Jun 29, 2026
LabMedica.com: Gene Expression Test Refines Melanoma Biopsy Decision-Making
Jun 24, 2026
OncLive: Risk Stratification at Diagnosis: Gene Expression Profiling and Surveillance Planning
May 29, 2026
ReachMD: Going Beyond Staging for Gene Expression Profiling in Melanoma and Cutaneous Squamous Cell Carcinoma
rss_feed RSS
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 29
  • Next Pagearrow_forward
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
©2026 Castle Biosciences, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement

Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.